Photocure ASA: Late-Breaking Plenary Presentation at the AUA 2017 Annual Meeting on Blue Light Flexible Cystoscopy with Hexaminolevinulate Phase 3 Study
Data on US Registry Study for BLC(TM) with Cysview/Hexvix will also be Presented at AUA Oslo, Norway, April 26, 2017: Photocure ASA (Photocure, PHO:OSE), today announced that results from the BLFC with Cysview®/Hexvix® Phase 3 study will be presented during a late-breaking plenary session at the American Urological Association (AUA) Annual Meeting in Boston, Mass., May 12-16, 2017. The late-breaking presentation will report results from a prospective multi-center study, carried out at 17 centers in the United States (US), on detection and impact on patient management of Cysview in